Skip to main content
OpenTrials
Completed

NCT Number: NCT00743808

Hypertension and Diabetes Initiative - Improving Hypertension Control in Individuals With Diabetes

Twelve health organizations from around the US were selected to participate in a chart review Hypertension and Diabetes Initiative with the goal of improving blood pressure control in persons with diabetes.

Hypothesis:

A three-phase quality improvement initiative facilitated and monitored through the International Diabetes Center (IDC) will result in improved population-mean systolic blood pressure in the aggregate data pool of patients from all 12 participating sites at geographically distinct health systems.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Phase 1 - Preparation: Each participating site begins to organize itself for the project. Baseline data will be collected and will be used to benchmark where each site is relative to blood pressure control/management of persons with diabetes prior to the implementation of the training programs.

Phase 2 - Implementation: Sites begin to address the gaps they have identified that affect blood pressure outcomes of patients with diabetes. IDC provides two on-site training programs for providers and support staff.

Phase 3 - Follow-up: IDC provides on-going support to each site via individual and collaborative conference calls and resources on the project Web site. Patient and visit data (audit form) will be collected six and 12 months after training. This data will be compared to the site's pre-training data.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ICD-9 Code 250 (indicates type 1 or type 2 diabetes)
  • ICD- Code 648.0 (indicates pregnancy with type 1 or type 2 diabetes)
  • ICD-9 Code 357.2 or 362.0, indicating complications of diabetes.
  • A prescription for insulin or oral hypoglycemic agents
  • Include those 18-75 years

Exclusion criteria

  • Attend a dialysis unit (if the nephrologist is primary care manager)
  • Have gestational diabetes (ICD-9 Code 648.8)
  • Have a terminal illness (e.g., hospice patient)
  • Do not have a documented blood pressure within the past year (this is asked on the audit form)

Treatment and study plan

Quality Improvement

Other

3-phase quality improvement intervention

Primary outcomes

  1. Systolic blood pressure

    Time frame: 1 year

Secondary outcomes

  1. Measure changes in action taken related to improving blood pressure management as percent of providers reporting changing (initiating or adjusting) blood pressure medication

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

HealthPartners Institute

Other

Collaborators

  • Advocate Medical Group
  • Baystate Health
  • Columbia Park Medical Group
  • Corewell Health East
  • Humboldt Del Norte Independent Practice Association
  • Metropolitan Health
  • Novartis
  • Park Nicollet Clinic
  • PeaceHealth Medical Group
  • Sanford Clinic
  • TriHealth Inc.
  • University Hospitals Medical Practices
  • Warren Clinic

Registry information

Official study title

Improving Hypertension Control in Individuals With Diabetes

Important dates

Study start
2006
Primary completion
2008
Study completion
2010
First posted
Aug 29, 2008
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.